Reaction

Sinus Arrest reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,526 reports · 34 co-occurring drugs

As of the last recalculation, Sinus Arrest appears in 1,526 FAERS reports alongside 34 co-occurring drug terms. The strongest observed disproportionality signal is TICAGRELOR (PRR 51.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Ticagrelor11251.651.8
Sevoflurane2338.338.4
Atropine2135.035.1
Atropine Sulfate2329.529.5
Rocuronium Bromide2529.429.5
Guanfacine1526.226.3
Lithium Carbonate2923.723.8
Propofol6123.723.7
Bupivacaine1623.623.6
Telmisartan2620.220.2
Diltiazem Hydrochloride Extended-Release Tablets1518.118.2
Dronedarone1317.517.5
Heparin Sodium1717.017.1
Nebivolol1815.615.6
Midazolam2815.415.4
Midazolam Hydrochloride2613.413.4
Remdesivir1212.412.4
Lacosamide3312.312.4
Metolazone1012.212.2
Phenytoin1811.911.9
Donepezil Hydrochloride3011.411.4
Isosorbide Mononitrate1711.311.3
Bleomycin Sulfate810.610.6
Ranolazine810.510.5
Valsartan Oral4010.310.3
Carbamazepine4910.310.3
Rivastigmine1410.210.2
Insulin Glulisine79.49.4
Sotalol Hydrochloride108.28.3
Nebivolol Hydrochloride208.28.2
Tafamidis67.07.0
Icosapent Ethyl46.46.4
Fentanyl Citrate75.45.4
Lenvatinib125.05.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.